Robby Keith, MD
Critical Care Medicine · South Charleston, WVNPI 1497781082
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.7%), education and travel and lodging — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Intuitive Surgical at 35.6% of the total. Reporting peaked in 2023 at $5,622 and has fallen 82.7% since, to $974 in 2025. Among critical care medicine clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 350 payments — averaging $34.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- Pulmonx Corporation$1K
- GSK$1K
- Regeneron Healthcare Solutions, Inc.$784
- Actelion Pharmaceuticals US, Inc.$774
- Sanofi$723
- plus $3K from 27 others
What the payments were for
- Travel & lodging$1,87116%
- Food & beverage$7,03959%
- Education$3,08926%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 8 | $4,275 |
| Pulmonx Corporation | 21 | $1,439 |
| GSK | 93 | $1,366 |
| Regeneron Healthcare Solutions, Inc. | 30 | $784 |
| Actelion Pharmaceuticals US, Inc. | 30 | $774 |
| Sanofi | 27 | $723 |
| Boehringer Ingelheim | 24 | $470 |
| AstraZeneca(2 entities) | 22 | $429 |
| Axsome Therapeutics, Inc. | 7 | $161 |
| Grifols USA, LLC | 10 | $159 |
| Genentech USA, Inc. | 9 | $143 |
| United Therapeutics Corporation | 6 | $132 |
| Electromed, Inc. | 11 | $118 |
| Insmed, Inc. | 5 | $102 |
| Mylan Specialty L.p. | 5 | $88 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $87 |
| Jazz Pharmaceuticals Inc. | 5 | $86 |
| Amgen | 5 | $82 |
| Verona Pharma, Inc. | 3 | $69 |
| Sunovion Pharmaceuticals Inc. | 4 | $67 |
| Baxter Healthcare | 3 | $67 |
| Eisai Inc. | 3 | $60 |
| Merck | 4 | $57 |
| Harmony Biosciences LLC | 2 | $45 |
| Pfizer | 2 | $42 |
| Viatris Specialty LLC | 2 | $34 |
| AbbVie(2 entities) | 2 | $26 |
| Vifor Pharma, Inc. | 1 | $25 |
| Mallinckrodt Enterprises LLC | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Advanced Respiratory, Inc | 1 | $17 |
| La Jolla Pharmaceutical Company | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ION$3,000
- Da Vinci Surgical System$1,207
- ZEPHYR ENDOBRONCHIAL VALVE$943
- CHARTIS CATHETER$152
- ZEPHYR DELIVERY CATHETER$152
- PULMONX CHARTIS TABLET CONSOLE$152
- FASENRA$135
- DUPIXENT$120
How this compares
$11,999 in reported general payments places this provider in the 90th percentile of 29 critical care medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OpsumitMacitentan | 35 | $452,458 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 360 | $373,678 |
| OfevNintedanib Esylate | 14 | $182,061 |
| Dupixent PenDupilumab | 46 | $178,286 |
| Prolastin CAlpha-1-Proteinase Inhibitor | 12 | $156,482 |
| NucalaMepolizumab | 25 | $103,276 |
| Ambrisentan | 31 | $86,692 |
| Breo ElliptaFluticasone/Vilanterol | 141 | $84,780 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 113 | $76,501 |
| SymbicortBudesonide/Formoterol Fumarate | 145 | $64,160 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 86 | $62,297 |
| EliquisApixaban | 63 | $53,194 |
| Spiriva RespimatTiotropium Bromide | 64 | $52,954 |
| Spiriva HandihalerTiotropium Bromide | 46 | $46,010 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 60 | $38,127 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Nucala, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $1,366 | $674,185717 claims |
| Actelion Pharmaceuticals US, Inc.Opsumit | $774 | $452,45835 claims |
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat, Combivent Respimat | $470 | $280,868149 claims |
| Grifols USA, LLCProlastin C | $159 | $156,48212 claims |
| AstraZenecaSymbicort, Breztri Aerosphere, Bevespi Aerosphere | $429 | $133,873243 claims |
| PfizerEliquis | $42 | $53,19463 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $21 | $6,03922 claims |
| MerckBelsomra | $57 | $4,69911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 29 critical care medicine providers in West Virginia.
Other critical care medicine in South Charleston
- Phillip CoxSouth Charleston$20K
- Kevin EgglestonSouth Charleston$13K
- James PerrySouth Charleston$12K
- Tamejiro TakuboSouth Charleston$10K
- William WadeSouth Charleston$7K
- Parag ChaudhariMorgantown$8K
- William BeamHuntington$2K
- Brownhilda SantoParkersburg$2K
- Zan ShareefCharleston$2K
- Kaitlin McDadeCharleston$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.